Oncology & Hematology Coding Alert

CMS:

Report to Medicaid and Medicare? 2 Issues You Need to Know Now

Keep up with the latest on NDCs and the OIG Work Plan.Crossover areas for Medicare and Medicaid are in the news. Here are the details on following CMS's new rule on adding NDC codes on Medicare claims and the OIG Work Plan's focus on Part B drug savings.1. CMS: Add NDC for Every HCPCSKeep an eye out for patients who are entitled to both Medicare and Medicaid, CMS states in MLN Matters SE1234. Effective Sept. 5, 2012, there are new national drug code (NDC) requirements for reporting physician-administered drugs.To quote the MLN instruction, you should follow these rules on the electronic claim to Medicare:For each line level reporting of a Part B physician-administered drug, continue to report the associated HCPCS (e.g., J3140) in 2400 SV202-2, with SV202-1=HC; andFor each Part B drug HCPCS reported in 2400 SV202-2, complete the required associated 2410 LIN and CPT04 segments as follows: Include the [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All